RNA-Targeted Small Molecules Market
完整報告名稱與涵蓋範圍
RNA-Targeted Small Molecules Market Size, Share & Trends Analysis Report By Product & Service (mRNA translation regulation, Indirect RNA targeting-epitranscriptomics, RNA Splicing Modification, Direct RNA Targeting), By Application (Drug discovery, Oncology research, Disease identification), By End-User, By Region, And By Segment Forecasts, 2024-2031
報告摘要
The RNA-Targeted Small Molecules Market on a global scale was estimated at USD 2.24 billion in 2023 and is set to attain USD 3.60 billion by 2031, with a projected CAGR of 6.29% between 2024 and 2031.
At its core, RNA-Targeted Small Molecules pertains to landscape are risingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global RNA-Targeted Small Molecules Market Snapshot
Chapter 4. Global RNA-Targeted Small Molecules Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global RNA-Targeted Small Molecules Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on RNA-Targeted Small Molecules Industry Trends
Chapter 5. RNA-Targeted Small Molecules Market Segmentation 1: By Product & Service, Estimates & Trend Analysis
5.1. Market Share by Product & Service, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product & Service:
5.2.1. mRNA Translation Regulation
5.2.2. Indirect RNA Targeting-Epitranscriptomics
5.2.3. RNA Splicing Modification
5.2.4. Direct RNA Targeting
Chapter 6. RNA-Targeted Small Molecules Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Applications:
6.2.1. Drug Discovery
6.2.2. Oncology Research
6.2.3. Disease Identificatio
Chapter 7. RNA-Targeted Small Molecules Market Segmentation 3: By End user, Estimates & Trend Analysis
7.1. Market Share by End user, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End users:
7.2.1. Hospitals
7.2.2. Research Laboratories
7.2.3. Contract Research Organizations
7.2.4. Pharmaceutical and Biotechnology Companies
Chapter 8. RNA-Targeted Small Molecules Market Segmentation 6: Regional Estimates & Trend Analysis
8.1. Global RNA-Targeted Small Molecules Market, Regional Snapshot 2023 & 2031
8.2. North America
8.2.1. North America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031
8.2.3. North America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. North America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031
8.3. Europe
8.3.1. Europe RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031
8.3.3. Europe RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Europe RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031
8.4. Asia Pacific
8.4.1. Asia Pacific RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031
8.4.3. Asia Pacific RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.4. Asia Pacific RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts By End user, 2024-2031
8.5. Latin America
8.5.1. Latin America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031
8.5.3. Latin America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Latin America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031
8.6. Middle East & Africa
8.6.1. Middle East & Africa RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031
8.6.3. Middle East & Africa RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by application, 2024-2031
8.6.4. Middle East & Africa RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AstraZeneca
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Offerings
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Pfizer
9.2.3. Bentham Scienc
9.2.4. PharmTech
9.2.5. Nymirum Inc.
9.2.6. Accent Therapeutics
9.2.7. Anima Biotech Inc.
9.2.8. Expansion Therapeutics
9.2.9. Bristol-Myers Squibb
9.2.10. Novartis
9.2.11. Other Market Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們